# NexPoint Life Sciences DST — Form D/A

NexPoint Life Sciences DST of DALLAS, TX, a company, filed a Form D amendment with the SEC on 2022-04-05. The offering totals $107.6M, of which $89.0M was reported sold. Industry: Other Real Estate.

## Offering

- Filed: 2022-04-05
- Form: D/A
- Accession: 0001901493-22-000008
- Industry: Other Real Estate
- Exemptions: 06b
- Total offering: $107.6M
- Amount sold: $89.0M
- Remaining: $18.6M
- Minimum investment: $100K
- Investors: 196
- Date of first sale: 2021-12-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-426919

## Issuer

- Name: NexPoint Life Sciences DST
- CIK: 0001901493
- Entity type: Other
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 300 CRESCENT COURT, DALLAS, TX, 75201
- Phone: (833) 697-6246

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Matt McGraner | Executive Officer | Dallas, TX |
| N/A NexPoint Real Estate Advisors IV, L.P. | Executive Officer | Dallas, TX |
| Matthew Goetz | Executive Officer | Dallas, TX |
| N/A NREA Casper, LLC | Executive Officer | Dallas, TX |
| N/A NREA Casper Investment Co, LLC | Executive Officer | Dallas, TX |

## Other filings by this issuer (13)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-06-06](https://search.stillhousedata.com/formd/0001901493-22-000012) | D/A | $107.6M | $105.0M |
| [2022-05-24](https://search.stillhousedata.com/formd/0001901493-22-000011) | D/A | $107.6M | $104.5M |
| [2022-05-10](https://search.stillhousedata.com/formd/0001901493-22-000010) | D/A | $107.6M | $104.3M |
| [2022-04-26](https://search.stillhousedata.com/formd/0001920957-22-000004) | D/A | $107.6M | $102.2M |
| [2022-04-19](https://search.stillhousedata.com/formd/0001901493-22-000009) | D/A | $107.6M | $97.8M |
| [2022-03-22](https://search.stillhousedata.com/formd/0001901493-22-000007) | D/A | $107.6M | $81.8M |
| [2022-03-08](https://search.stillhousedata.com/formd/0001901493-22-000006) | D/A | $107.6M | $67.9M |
| [2022-02-23](https://search.stillhousedata.com/formd/0001901493-22-000005) | D/A | $107.6M | $39.9M |
| [2022-02-10](https://search.stillhousedata.com/formd/0001901493-22-000004) | D/A | $107.6M | $35.0M |
| [2022-01-26](https://search.stillhousedata.com/formd/0001901493-22-000003) | D/A | $107.6M | $24.2M |
| [2022-01-18](https://search.stillhousedata.com/formd/0001901493-22-000002) | D/A | $107.6M | $12.8M |
| [2022-01-04](https://search.stillhousedata.com/formd/0001901493-22-000001) | D/A | $107.6M | $5.3M |
| [2021-12-28](https://search.stillhousedata.com/formd/0001901493-21-000001) | D | $107.6M | $5.2M |

## More

- [CIK 1901493 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1901493&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001901493-22-000008.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.